Pfizer · NSE: PFIZER · BSE: 500680
Q3 FY19 results · Oct–Dec 2018
Pfizer reported revenue from operations of ₹513.79 crore and net profit of ₹131.94 crore for Q3 FY19 (Oct–Dec 2018), on a standalone basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 513.79 | — | — | 519.74 | −1.1% |
| Other income | 64.35 | — | — | 37.06 | +73.6% |
| Total income | 578.14 | — | — | 556.80 | +3.8% |
| Profit before tax | 200.62 | — | — | 148.88 | +34.8% |
| Net profit for the period | 131.94 | — | — | 95.80 | +37.7% |
| EPS, basic (₹) | 28.84 | — | — | 20.94 | +37.7% |
| Net margin (%) | 25.7 | — | 18.4 |
Standalone
- Filed with BSE
- 25 Jan 2019, 09:34 IST
- Board meeting
- 24 Jan 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE